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Summary: the domestic market of medications for local treatment of burns is investigated, their correlation is analysed 
according to the release forms, imported and domestic medications registered in Ukraine and their use under the ATC 
classi cation system. The analysis of medication assortment in the pharmaceutical markets of Poland and Russia is 
represented. 
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Introduction. The problem of burn wounds treatment 
is relevant today in Ukraine and all over the world be-
cause the burn pathologies are among the most com-
mon and serious types of injuries. Each year about 11 
million of people in the world ask for medical help, and 
300 000 of them die of burns. [1] About 4 % of taken 
to the burn center die from burn injuries in the United 
States of America [2]. In India, from 700 000 to 800 000 
people receive signi cant burns of varying severity, but 
very few of them ask for help to the specialists. [3] 80 
thousand people with burns are registered in Ukraine 
each year [4], 10 % of which are children. In Russia, the 
prevalence of the problem is in an average of 294.2 in-
cidents per 10 thousand of population [5]. Burn wounds 
involve high risk of infection of wounds, certain compli-
cations appear in the treatment and takes third place in 
the general structure of the injuries [6].
Would-healing medications (M) are used for local 
treatment of burns (LTB), that meet basic medical and 
biological requirements, especially, treatment that is 
aimed at antibacterial protection of burn wounds with 
prevention of secondary contamination, restoring of mi-
crocirculation and stabilization of biomembranes, keep-
ing vital functions of tissues and protection against me-
chanical damage, creating conditions for engraftment of 
transplanted parts of skin, as well as prevention of the 
formation of hypertrophic and keloid scars and acceler-
ating wound healing process [4, 6].
Today at the pharmaceutical market, there is a large 
number of medication available for local treatment of 
burns – ointments with antiseptics and antibiotics, gels, 
creams, pastes, sprays, aerosols, solutions for external 
use, biological medications.
Analysing, in more details, medications registered 
at the pharmaceutical markets of Russia and Poland, 
it has been studied those medications, which are not 
represented in Ukraine, especially sponges and plas-
ters.
The aim of study was to investigate the range of med-
ications for LTB and determine prospects for develop-
ment new medications.
Methods of the research. The object of study was 
information about registered medications at the ter-
ritory of Ukraine, posted on the website «Regulatory 
and directive documents of the Ministry of Healthcare 
of Ukraine» [7], and the method of derivative market-
ing information analysis was used too. «Compendium» 
was used as an informational source [8]. Online guides 
were used for analysis of medications that are used for 
burn wounds treatment in Russia and Poland [9, 10]. 
During the research, the following methods of analysis 
have been used: systematic and observation, graphic 
and documentary. 
Results and discussions. According to the results 
of the research on September 2015, there are 54 medi-
cations of different forms of release in Ukraine, which 
are directly used for LTB. This number of medications 
is much smaller comparing to the medications with the 
same features, that are registered at markets of Poland 
(72 medications) and Russia (63 medications).
According to the instructions of using medications, 
these preparations belong to the group that goes without 
a prescription and can be used for treatment of super -
cial and deep burns (II-III degrees) [9, 10, 11].
All investigated medications that are registered in 
Ukraine, Poland and Russia were analysed in the form 
of release according to the «Classi cation of medical 
form», approved by order of the Ministry of Healthcare 
of Ukraine No. 235 [12] (Fig. 1). 
 Analysis of medication range registered in Ukraine 
for burn treatment, showed that most of them are pre-
sented as soft dosage forms (DF) – 78 %, among them 
ointments are the most popular – 56.41 % , and creams 
– 23.08 %. The main position at markets of Poland and 
Russia is taken with soft medications, which have 75 % 
and almost 69 % respectively.
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After examining the domestic and foreign markets of 
studied medications in more details and comparing their 
range of products, we can conclude, there are certain dif-
ferences in presence of medications. In particular, there 
are no medications for LTB surfaces in the forms of pastes, 
balms, emulsions, plasters at the domestic market, while 
Fig. 1. Comparative analysis of medication markets in Poland, Russia, Ukraine to treat burns
Table 1. The range and number of medications for local treatment of burns at pharmaceutical market of Ukraine, Russia 
and Poland
No Kind of DF Number M in Ukraine Number M in Poland Number M in Russia
1 Ointment 22 29 24 
2 Gel 6 13 2 
3 Cream 9 11 7 
4 Liniment 6 - 2 
5 Pasta - 1 4 
6 Solutions for external use 5 - 6 
7 Aerosol 1 2 6 
8 Spray 2 6 1 
9 Tablets 1 - 2 
10 Powders 1 1 -
11 Capsules 1 1 -
12 Emulsion - 2 -
13 Balm - 1 2 
14 Plaster - 5 2 
15 Medical sponges - - 5 
in Poland there are no liniments and solutions for outward 
applications, and the rage of hard medications in Russia 
is very limited, including tablets soluble, which are used 
for dissolving in water to form a solution that should be 
used for the treatment of burn surfaces and to improve 
regeneration and wound healing (Table 1).
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After examining Polish and Russian markets of stud-
ied group of medications and comparing them with 
domestic, it has been found that there are registered 
medications such as medical sponges and plasters for 
LTB surfaces in Russia and Poland, which are not rep-
resented in Ukraine.
Particularly, 5 types of medications such as medical 
sponges, namely, «Meturakol», which contains Methylu-
racilum and dry collagen; «Alhimaf», which contains so-
dium alginate, calcium gluconate, mafenide acetate and 
phenosanic acid; «Alhypor», which contains sodium al-
ginate, calcium gluconate and furatsillina; «Sponge with 
kanamycin» (kanamycin, nitrofural) and «Kombutek-2», 
which contains collagen as a basis, glutaraldehyde, hi-
nozola and boric acid have been registered in Russia.
Polish pharmaceutical companies for the LTB produce 
plasters of different sizes based on hydrogel – «Derma-
Plast», «Urgo Burns». The medication, such as «Versi-
va XC», produced by «Bristol Myers Squibb» company, 
consists of natural and synthetic polymers (polyvinyl py-
rolidone, polyethylene glycol and agar) [10].
During the study it was taken into account medica-
tions, used for LTB, which are not composed of chemical 
substance or medicinal herbs as active pharmaceutical 
ingredients, but only biologically active materials. For 
example, medication «Solcoseryl» of Swiss production, 
which is registered in Poland, Ukraine and Russia, has 
no protein dialysate of the blood of calves, and can be 
used for burn treatment of I-II degrees. The medication 
«Kombutek 2» of Russian production, which is regis-
tered only in Russia and contains collagen as a basis 
taken from the Achilles tendon or skin of cattle, and it is 
used to treat burns of II-III A degrees.
The next stage of our research was the comparative 
analysis of the range of examined medications in Ukrai-
nian, Russian and Polish markets, depending on the 
country of manufacturers (Fig. 2). 
The results of the study of medication assortment for 
the LTB, registered in Ukraine, showed no signi cant 
difference in the ratio between imported (51.85 %) and 
domestic (48.15 %) medications and foreign produced 
medications have slightly predominating. 
In Poland and Russia, the ratio of medications pro-
duced by domestic manufacturers is much higher com-
paring to the number of imported products, especially the 
ratio of medications of domestic and imported production 
by Polish and Russian pharmaceutical market is equal to 
61.9 : 38.1 and 62.5 : 37.5 respectively [Fig. 2].
 At the Ukrainian market, medications for the local 
treatment of burns are represented by 10 countries, 
among which are the following leaders: Germany – 
25 %, Russia – 14.28 %, Poland – 10.71 %, Austria and 
Croatia 7.14 % each. Other countries import a small 
number of these medications and occupy together 35.73 
% of the imported range.
The medications used in the pharmacotherapy of 
burns, are produced by 15 pharmaceutical enterprises 
of different ownership in Ukraine. Due to the amount 
of production, leading position are occupied by PJSC 
«Lubnyfarm» (19.23 %), PJSC «Darnycya», PJSC «Vi-
ola» and joint Spanish-Ukrainian enterprise «Sperco 
Ukraine», which have 11.54 % each of the investigated 
medication market.
During researching of the Russian pharmaceutical 
market, it was found that 61,90 % of the studied medi-
cations are produced by Russian manufacturers. These 
Fig. 2. The diagram on distribution of domestic and imported medications for the local treatment of burns at the studied 
markets.
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medications are produced by 24 pharmaceutical enter-
prises of different ownership, among which are the fol-
lowing leaders: PJSC «Nizhpharm», CJSC «Varteks», 
«Akryhyn Chemical and pharmaceutical factory», JSC 
«Belkozin Luha Factory».
Imported medications have 38.10 % of the pharmaceu-
tical market; moreover, medications for LTB are imported 
to Russia from 14 countries. The leaders are Germany, 
Ukraine and Poland, the share of manufacturing companies 
is the following: 29.16 %, 16.67 % and 8.34 % respectively 
of the total range of the studied group of medications.
Studying the Polish market of medications, it was 
found, that 62.50 % of medications from total number of 
this range, used for LTB, are produced by Polish manu-
facturers, which include the following leaders: «Polfa» 
Grodzisk Pharmaceutical Works Sp.z.o.o., «UNIA» 
Pharmaceutical Plant Coop, «Jelfa» Pharmaceutical 
Works S.A, «CHEMA ELEKTROMET».
Medications for burn treatment are represented by 12 
countries at the Polish market, as at the Russian market 
among them are the following leaders: Germany – 25.93 
% and Switzerland – 14.81 %. Britain and Hungary im-
port 11.12 % each of the total number of studied medi-
cations, other countries have 37.02 % of the market and 
their import is not signi cant.
The obtained results of comparative studies of mar-
kets of Ukraine, Poland and Russia prove the feasibility 
and prospects for diversi cation of existing medications 
and creating new original domestic medications that 
could stimulate regenerative processes of the skin and 
improve healing of burn wounds.
Conclusions:
1. It was investigated, that as for the date of Septem-
ber 2015, in Ukraine there are 54 registered medica-
tions, 72 medications in Poland, and 63 medications in 
Russia for the local treatment of burns.
2. Most of the investigated medications are soft dos-
age forms, the share of which in Ukraine is 78 %, in Po-
land and Russia is 61.90 % and 75 % respectively.
3. It was determined that in Ukraine 51.85 % of all 
medications for treatment of burns are of foreign manu-
facturing, however Russia and Poland, where the share 
of imported medications is not signi cant, especially 
38.10 % and 37.50 % respectively.
4. During the study, it was found that in Russia and 
Poland for the local treatment of burns there are regis-
tered medications in the form of medical sponges and 
plasters, but there are no appropriate forms in Ukraine, 
so it creates prospects for developing these dosage 
forms in Ukraine.
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ПОРІВНЯЛЬНЕ ДОСЛІДЖЕННЯ РИНКІВ УКРАЇНИ, ПОЛЬЩІ ТА РОСІЇ ЩОДО НАЯВНОСТІ 
ЗАРЕЄСТРОВАНИХ ЛІКАРСЬКИХ ЗАСОБІВ ДЛЯ МІСЦЕВОГО ЛІКУВАННЯ ОПІКІВ
Б. В. Вонс, Т. А. Грошовий, М. Б. Чубка
ДВНЗ «Тернопільський державний медичний університет імені І. Я. Горбачевського МОЗ України»
Резюме: досліджено вітчизняний ринок лікарських засобів для місцевого лікування опіків, проаналізовано їх 
співвідношення згідно з формою випуску, розглянуто лікарські засоби імпортного та вітчизняного виробництва, 
які зареєстровані в Україні та їх застосування відповідно до АТС-класифікації. Проведено аналіз асортименту 
лікарських засобів представлених на фармацевтичних ринках Польщі та Росії.
Ключові слова: лікарські засоби, м’які лікарські форми, аналіз фармацевтичного ринку.
СРАВНИТЕЛЬНОЕ ИССЛЕДОВАНИЕ РЫНКОВ УКРАИНЫ, ПОЛЬШИ И РОССИИ О НАЛИЧИИ 
ЗАРЕГИСТРИРОВАННЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ ДЛЯ МЕСТНОГО ЛЕЧЕНИЯ ОЖОГОВ
Б. В. Вонс, Т. А. Грошовый, М. Б. Чубка
ДВНЗ «Тернопольский государственный медицинский университет имени И. Я. Горбачевского МЗ 
Украины»
Резюме: исследовано отечественный рынок лекарственных средств для местного лечения ожогов, 
проанализировано их соотношение по форме выпуска, рассмотрены лекарственные средства импортного 
и отечественного производства, которые зарегистрированы в Украине и их применение в соответствии с АТС-
классификации. Проведен анализ ассортимента лекарственных средств представленных на фармацевтических 
рынках Польши и России.
Ключевые слова: лекарственные средства, мягкие лекарственные формы, анализ фармацевтического рынка.
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